• OPEN AN ACCOUNT
Indian Indices
Nifty
24,680.90 -156.10
(-0.63%)
Sensex
80,891.02 -572.07
( -0.70%)
Bank Nifty
56,084.90 -444.00
( -0.79%)
Nifty IT
35,370.05 -253.70
( -0.71%)
Global Indices
Nasdaq
44,929.79 214.87
(0.48%)
Dow Jones
6,410.96 26.61
(0.42%)
Hang Seng
41,045.60 -410.63
(-0.99%)
Nikkei 225
9,120.31 -18.06
(-0.20%)
Forex
USD-INR
86.38 0.01
(0.01%)
EUR-INR
101.61 0.16
(0.16%)
GBP-INR
116.99 -0.03
(-0.02%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Indifra Ltd
Industry :  Diversified - Medium / Small
BSE Code
ISIN Demat
Book Value()
91807
INE0PS301014
24.9108368
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDIFRA
1750
12.76
EPS(TTM)
Face Value()
Div & Yield %
0.01
10
0
 

crompton greaves ltd
Bliss GVS Pharma Ltd - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025
Jul 22,2025
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025. Please find enclosed intimation in this regard